<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.
--------------------
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): October 16, 2000
Gliatech Inc.
---------------------------------------------------------
(Exact name of registrant as specified in its charter)
Delaware 0-20096 34-1587242
-------- ------- ----------
(State or other (Commission File Number) (I.R.S. Employer
jurisdiction of Identification No.)
incorporation)
23420 Commerce Park Road, Cleveland, Ohio 44122
----------------------------------------- ----------
(Address of Principal Executive Offices) (Zip Code)
Registrant's telephone number, including area code: (216) 831-3200
--------------
<PAGE> 2
Item 5. Other Events.
-------------
On August 23, 2000, the Food and Drug Administration (the "FDA") issued
a Form FDA 483 to the Company, which cited observations of the FDA. On
September 14, 2000, the Company issued a response to the FDA regarding
the Form FDA 483. A redacted copy of the Company's response is filed as
Exhibit 99.1 hereto and is incorporated herein by reference thereto. In
addition, the Company issued a press release on October 16, 2000
relating to such response to the Form FDA 483, a copy of which is filed
as Exhibit 99.2 hereto and is incorporated herein by reference thereto.
Item 7. Financial Statements and Exhibits.
----------------------------------
(a) None.
(b) None.
(c) Exhibits
99.1 The Company's response to the Form FDA 483, dated as of
September 14, 2000.
99.2 Press Release, dated October 16, 2000, issued by the Company.
<PAGE> 3
SIGNATURE
---------
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
GLIATECH INC.
By:/s/ Rodney E. Dausch
--------------------
Name: Rodney E. Dausch
Title: Chief Operating Officer and
Secretary
Dated: October 16, 2000
<PAGE> 4
EXHIBIT INDEX
-------------
EXHIBIT NO. EXHIBIT
----------- -------
99.1 The Company's response to the Form FDA 483, dated as
of September 14, 2000.
99.2 Press Release, dated October 16, 2000, issued by the
Company.
